BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 8510707)

  • 21. Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency.
    du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2006 Feb; 21(2):389-96. PubMed ID: 16234291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membranous nephropathy related to hepatitis B virus in adults.
    Lai KN; Li PK; Lui SF; Au TC; Tam JS; Tong KL; Lai FM
    N Engl J Med; 1991 May; 324(21):1457-63. PubMed ID: 2023605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy.
    Hofstra JM; Deegens JK; Steenbergen EJ; Wetzels JF
    Nephrol Dial Transplant; 2008 Oct; 23(10):3160-5. PubMed ID: 18403431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults.
    Davison AM; Cameron JS; Kerr DN; Ogg CS; Wilkinson RW
    Clin Nephrol; 1984 Aug; 22(2):61-7. PubMed ID: 6478673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of sex in primary glomerulonephritis.
    Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
    Ponticelli C; Zucchelli P; Passerini P; Cesana B
    N Engl J Med; 1992 Aug; 327(9):599-603. PubMed ID: 1640953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remissions and relapses in idiopathic membranous nephropathy.
    Ponticelli C; Passerini P; Altieri P; Locatelli F; Pappalettera M
    Nephrol Dial Transplant; 1992; 7 Suppl 1():85-90. PubMed ID: 1337188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Membranous nephropathy: recurrence after kidney transplantation.
    Marcen R; Mampaso F; Teruel JL; Rivera ME; Orofino L; Navarro-Antolin J; Ortuño J
    Nephrol Dial Transplant; 1996 Jun; 11(6):1129-33. PubMed ID: 8671981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppressive therapy with cyclophosphamide and prednisolone in severe idiopathic membranous nephropathy.
    Kibriya MG; Tishkov I; Nikolov D
    Nephrol Dial Transplant; 1994; 9(2):138-43. PubMed ID: 8190328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary IgG excretion as a prognostic factor in idiopathic membranous nephropathy.
    Reichert LJ; Koene RA; Wetzels JF
    Clin Nephrol; 1997 Aug; 48(2):79-84. PubMed ID: 9285143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporin A treatment for idiopathic membranous nephropathy.
    Yao X; Chen H; Wang Q; Tang Z; Hu W; Yin G; Liu Z; Li L
    Chin Med J (Engl); 2001 Dec; 114(12):1305-8. PubMed ID: 11793859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiopathic membranous nephropathy in the elderly.
    Passerini P; Como G; Viganò E; Melis P; Pozzi C; Altieri P; Ponticelli C
    Nephrol Dial Transplant; 1993; 8(12):1321-5. PubMed ID: 8159299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical course and prognostic factors in lupus nephropathy].
    Gamba G; Quintanilla L; del Bosque MD; Chew-Wong A; Correa-Rotter R
    Rev Invest Clin; 2000; 52(4):397-405. PubMed ID: 11061101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The therapy of idiopathic membranous glomerulonephritis.
    Glassock RJ
    Semin Nephrol; 1991 Mar; 11(2):138-47. PubMed ID: 2034923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membranous nephropathy. Long-term follow-up and association with neoplasia.
    Row PG; Cameron JS; Turner DR; Evans DJ; White RH; Ogg CS; Chantler C; Brown CB
    Q J Med; 1975 Apr; 44(174):207-39. PubMed ID: 1178811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy.
    McQuarrie EP; Stirling CM; Geddes CC
    Nephrol Dial Transplant; 2012 Jan; 27(1):235-42. PubMed ID: 21558430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low glomerular density is a risk factor for progression in idiopathic membranous nephropathy.
    Tsuboi N; Kawamura T; Miyazaki Y; Utsunomiya Y; Hosoya T
    Nephrol Dial Transplant; 2011 Nov; 26(11):3555-60. PubMed ID: 21771759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C; Zucchelli P; Imbasciati E; Cagnoli L; Pozzi C; Passerini P; Grassi C; Limido D; Pasquali S; Volpini T
    N Engl J Med; 1984 Apr; 310(15):946-50. PubMed ID: 6366560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
    Peters HP; van den Brand JA; Wetzels JF
    Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study.
    Haas M; Mayer G; Wirnsberger G; Holzer H; Ratschek M; Neyer U; Neuweiler J; Kramar R; Schneider B; Breiteneder-Geleff S; Regele HM; Hörl WH; Kerjaschki D
    Wien Klin Wochenschr; 2002 Feb; 114(4):143-7. PubMed ID: 12060980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.